FCER2 and B-cell chronic lymphocytic leukemia: Exceptional LBCL, IRF4+ cases with CD5 or CD23 expression need to be distinguished from prolymphocytic progression or large cell transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.